These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16724208)

  • 21. Biologic behavior of microsatellite-unstable colorectal cancer and treatment with 5-fluorouracil.
    Niv Y
    Isr Med Assoc J; 2005 Aug; 7(8):520-4. PubMed ID: 16106779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection.
    Liang JT; Huang KC; Lai HS; Lee PH; Cheng YM; Hsu HC; Cheng AL; Hsu CH; Yeh KH; Wang SM; Tang C; Chang KJ
    Int J Cancer; 2002 Oct; 101(6):519-25. PubMed ID: 12237891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical implications of microsatellite instability in T1 colorectal cancer.
    Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
    Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting the Efficacy of 5-Fluorouracil-Based Adjuvant Chemotherapy in Gastric Cancer by Microsatellite Instability: A Meta-Analysis.
    Zhao F; Yuan X; Ren D; Shen G; Wang Z; Zheng F; Ahmad R; Ma Z; Zhao J
    J Environ Pathol Toxicol Oncol; 2019; 38(1):21-28. PubMed ID: 30806287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group.
    Müller CI; Schulmann K; Reinacher-Schick A; Andre N; Arnold D; Tannapfel A; Arkenau H; Hahn SA; Schmoll SH; Porschen R; Schmiegel W; Graeven U;
    Int J Colorectal Dis; 2008 Nov; 23(11):1033-9. PubMed ID: 18594845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic and predictive significance of microsatellite instability in stage II colorectal carcinoma: An 8-year study from a tertiary center in South India.
    Paulose RR; Ail DA; Biradar S; Vasudevan A; Sundaram KR
    Indian J Cancer; 2019; 56(4):302-308. PubMed ID: 31607697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microsatellite instability and sensitivity to fluoropyrimidine and oxaliplatin containing first-line chemotherapy in metastatic colorectal cancer.
    Liu J; Wang B; Fang W
    Eur J Hosp Pharm; 2020 Sep; 27(5):267-270. PubMed ID: 32839257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of TP53 mutation is more relevant than microsatellite instability status for the prediction of disease-free survival in adjuvant-treated stage III colon cancer patients.
    Westra JL; Schaapveld M; Hollema H; de Boer JP; Kraak MM; de Jong D; ter Elst A; Mulder NH; Buys CH; Hofstra RM; Plukker JT
    J Clin Oncol; 2005 Aug; 23(24):5635-43. PubMed ID: 16110022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
    Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
    Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy.
    Brueckl WM; Moesch C; Brabletz T; Koebnick C; Riedel C; Jung A; Merkel S; Schaber S; Boxberger F; Kirchner T; Hohenberger W; Hahn EG; Wein A
    Anticancer Res; 2003; 23(2C):1773-7. PubMed ID: 12820457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
    Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
    Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Long-Term Outcomes of Microsatellite Instability Status in an Asian Cohort of Sporadic Colorectal Cancers.
    Tan WJ; Hamzah JL; Acharyya S; Foo FJ; Lim KH; Tan IBH; Tang CL; Chew MH
    J Gastrointest Cancer; 2018 Sep; 49(3):311-318. PubMed ID: 28550452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of disease-free survival in colorectal cancer with microsatellite instability: An AGEO multicentre study.
    Tougeron D; Sickersen G; Mouillet G; Zaanan A; Trouilloud I; Coriat R; Aparicio T; Des Guetz G; Lecaille C; Artru P; Cauchin E; Sefrioui D; Boussaha T; Ferru A; Matysiak-Budnik T; Silvain C; Karayan-Tapon L; Pagès JC; Vernerey D; Bonnetain F; Michel P; Taïeb J; Lecomte T;
    Eur J Cancer; 2015 May; 51(8):925-34. PubMed ID: 25864037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis.
    Des Guetz G; Schischmanoff O; Nicolas P; Perret GY; Morere JF; Uzzan B
    Eur J Cancer; 2009 Jul; 45(10):1890-6. PubMed ID: 19427194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
    Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
    Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
    Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite instability as a marker of prognosis and response to therapy: a meta-analysis of colorectal cancer survival data.
    Guastadisegni C; Colafranceschi M; Ottini L; Dogliotti E
    Eur J Cancer; 2010 Oct; 46(15):2788-98. PubMed ID: 20627535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry.
    Chong LC; Townsend AR; Young J; Roy A; Piantadosi C; Hardingham JE; Roder D; Karapetis C; Padbury R; Maddern G; Moore J; Price TJ
    Target Oncol; 2019 Feb; 14(1):85-91. PubMed ID: 30659494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
    Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
    Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.